breast carcinoma – MySymptom

Cystic Hypersecretory Carcinoma: Pathophysiology, Diagnosis, and Treatment

1. Introduction Cystic hypersecretory carcinoma is an exceedingly rare and morphologically distinct variant of breast ductal carcinoma. This unique neoplastic condition is defined by the profound cystic dilatation of the breast ducts and the excessive production of a specialized, thick secretory material that strikingly resembles thyroid colloid under microscopic examination. The clinical discovery of a … Read more

Intraductal Micropapillary Carcinoma: Diagnosis and Treatment Guidelines

1. Introduction to Intraductal Micropapillary Carcinoma Intraductal micropapillary carcinoma is a distinct, aggressive morphological variant of ductal carcinoma in situ. It is defined by a unique microscopic growth pattern where the malignant epithelial cells form delicate, club-shaped projections extending directly into the lumen of the milk ducts. While it shares the “in situ” classification with … Read more

Malignant Ductal and Lobular Neoplasms: Pathology, Diagnosis, and Treatment Options

1. Introduction to Malignant Breast Neoplasms Malignant ductal and lobular neoplasms represent the two primary categories of invasive carcinoma originating within the glandular tissues of the breast. The defining characteristic of these malignancies is their biological ability to breach normal anatomical boundaries. The abnormal epithelial cells escape their original structural confines and infiltrate the surrounding … Read more

Adenomyoepithelioma with Carcinoma: Breast Pathology and Treatment

1. Introduction Adenomyoepithelioma with carcinoma is a rare breast malignancy that develops when a typically benign biphasic tumor, composed of both epithelial and myoepithelial cells, undergoes malignant transformation. The bottom line is that identifying the malignant component within this complex nodule is crucial, as it dictates the necessity for wide surgical excision, precise margin evaluation, … Read more

HER2-Positive Breast Cancer: Biology, Clinical Presentation, and Targeted Therapies

1. Introduction to HER2-Positive Carcinomas HER2-positive breast carcinoma represents a highly specific and clinically significant molecular subtype of breast cancer, accounting for approximately twenty percent of all breast cancer diagnoses. This specific malignancy is defined by the profound overproduction of the Human Epidermal Growth Factor Receptor 2 protein on the surface of the tumor cells. … Read more